Sérgio Orlando

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study

Camila Peña, Eloísa Riva, Natalia Schütz et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2020 · 28 citations · Full text

Medicine, Hematology, Oncology +14

Decitabine in myelodysplastic syndromes and chronic myelomonocytic leukemia: Argentinian/South Korean multi-institutional clinical experience

Marcelo Iastrebner, Jun Ho Jang, Elsa Nucifora et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 15 citations

Medicine, Hematology, Pharmacotherapy +16

ESICM LIVES 2016: part three

T. Velasquez, J. Lusk, Ursula G. Kyle et al. · Intensive Care Medicine Experimental · 2016 · 12 citations · Full text

Computing, Health Services Administration, Health Systems Leadership +5

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Humberto Martínez‐Cordero, Camila Peña, Natalia Schütz et al. · JCO Global Oncology · 2023 · 11 citations · Full text

Medicine, Hematology, Internal Medicine +13

Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

Natalia Schütz, Paola Ochoa, Patricio Duarte et al. · Hematological Oncology · 2020 · 10 citations

Medicine, Hematology, Pharmacotherapy +17